
Developing disease-resistant crops through protein engineering.

Ohmic Biosciences, founded with a mission to revolutionize agricultural biotechnology, focuses on genetically engineering plants for enhanced disease resistance. The company leverages cutting-edge protein engineering and synthetic biology to design robust resistance genes, aiming to combat the significant economic impact of pests and pathogens on global agriculture. Ohmic Biosciences offers innovative solutions that surpass traditional agrochemicals, targeting a broad market of crop producers seeking sustainable and effective disease management strategies.
Notable figures affiliated with Ohmic Biosciences include leading experts in biotechnology and synthetic biology, who drive the company's research and development efforts. The startup has attracted significant interest from investors focused on sustainable agriculture and biotech innovation. Key achievements include the successful development of several disease-resistant crop prototypes, demonstrating the practical application of their technology. Overall, Ohmic Biosciences is making a substantial impact by providing durable, science-driven solutions to agricultural challenges, promoting a more resilient and productive global food system.

SynsoryBio
synsorybio.com

Robigo
robigo.bio

Omni Biosciences

Organicin Scientific

Lytos Technologies
lytostech.com

Omnilytics
omnilytics.com

Rev Genomics
revgenomics.com

Ginkgo Bioworks
ginkgobioworks.com

Innate Immunity

Oerth Bio
oerthbio.com

Ochre Bio
ochre-bio.com

Invitris
invitris.com

Seedling Biosystems
seedling.bio

Bluestem Biosciences

ResVita Bio
resvitabio.com
Companies similar to Ohmic Biosciences include SynsoryBio, Robigo, Omni Biosciences and Organicin Scientific.
Ohmic Biosciences was founded in 2021.
Ohmic Biosciences' most recent funding round was for $500k (USD) in June 2023.
As of Jun 1, 2023, Ohmic Biosciences has raised a total of $500k (USD).
Ohmic Biosciences has 2 employees as of Sep 2, 2023.